Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal Disease
Status:
Unknown status
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effects of the digibind drug on hemodialysis
patients with high blood pressure. Digibind is used to treat toxicity from digoxin and
digoxin-like molecules which may contribute to high blood pressure.